22 Recruiting Glioblastoma Multiforme Phase 2 Clinical Trials
Active phase 2 studies for glioblastoma multiforme enrolling across the USA. Verify eligibility and contact site coordinators.
All Glioblastoma Multiforme studiesPhase 2 Studies for Glioblastoma Multiforme
A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme
📍 Holden Comprehensive Cancer Center — Iowa City, Iowa
View Study & Checklist ➔Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)
📍 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland
View Study & Checklist ➔Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme
📍 Sibley Memorial Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM
📍 Center for Neurosciences — Tucson, Arizona
View Study & Checklist ➔Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM
📍 Duke University Medical Center — Durham, North Carolina
View Study & Checklist ➔A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)
📍 Research Site — Los Angeles, California
View Study & Checklist ➔Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
📍 University of Southern California — Los Angeles, California
View Study & Checklist ➔Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM
📍 Montreal Neurological Institute - McGill University Health Centre — Montreal, Quebec
View Study & Checklist ➔NG101m Adjuvant Therapy in Glioblastoma Patients
📍 Yvonne Kew MD, PLLC — Houston, Texas
View Study & Checklist ➔Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
📍 Lenox Hill Brain Tumor Center — New York, New York
View Study & Checklist ➔Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
📍 University of California at Los Angeles — Los Angeles, California
View Study & Checklist ➔HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
📍 Houston Methodist Neurological Institute — Houston, Texas
View Study & Checklist ➔Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma
📍 CHUS — Sherbrooke, Quebec
View Study & Checklist ➔Tamoxifen Versus Etoposide After First Recurrence in GBM Patients
📍 Cross Cancer Institute — Edmonton, Alberta
View Study & Checklist ➔Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients
📍 Arthur J.E. Child Comprehensive Cancer Center (formerly Tom Baker Cancer Centre) — Calgary, Alberta
View Study & Checklist ➔A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
📍 University of Virginia — Charlottesville, Virginia
View Study & Checklist ➔Study of Pembrolizumab and M032 (NSC 733972)
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)
📍 University Hospitals Cleveland Medical Center — Cleveland, Ohio
View Study & Checklist ➔IA Carboplatin + Radiotherapy in Relapsing GBM
📍 CHUS — Sherbrooke, Quebec
View Study & Checklist ➔Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
📍 Jackson Memorial Hospital — Miami, Florida
View Study & Checklist ➔